title: Diagnosis and treatment of catheter-related infections in paediatric oncology: an update.
abstract: Otherwise unexplained clinical signs of infection in patients with long-term tunnelled or totally implanted central venous access devices (CVADs) are suspected to be CVAD-associated. Diagnostic methods include catheter swabs, blood cultures and cultures of the catheter tip or port reservoir. In the case of a suspected CVAD-related bloodstream infection in paediatric oncology patients, in-situ treatment without prompt removal of the device can be attempted. Removal of the CVAD should be considered if bacteraemia persists or relapses > or = 72 h after the initiation of (in-vitro effective) antibacterial therapy administered through the line. Timely removal of the device is also recommended if the patient suffers from a complicated infection, or if Staphylococcus aureus, Pseudomonas aeruginosa, multiresistant Acinetobacter baumannii or Candida spp. are isolated from blood cultures. Duration of therapy depends on the immunological recovery of the patient, the pathogen isolated and the presence of related complications, such as thrombosis, pneumonia, endocarditis and osteomyelitis. Antibiotic lock techniques in addition to systemic treatment are beneficial for Gram-positive infections. Although prospectively controlled studies are lacking, the concomitant use of urokinase locks and taurolidine secondary prophylaxis seem to favour catheter salvage.
authors.affiliation: Department of Paediatric Haematology and Oncology, Children's Hospital Medical Centre, University of Bonn, Bonn, Germany. asimon@ukb.uni-bonn.de
authors.forename: A
authors.initials: A
authors.lastname: Simon
authors.forename: U
authors.initials: U
authors.lastname: Bode
authors.forename: K
authors.initials: K
authors.lastname: Beutel
mesh_terms: D000165:Acridine Orange; D000465:Algorithms; D016470:Bacteremia / Q000175:diagnosis* / Q000188:drug therapy; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000382:microbiology*; D002648:Child; D002985:Clinical Protocols; D003428:Cross Infection / Q000382:microbiology* / Q000517:prevention & control; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis / Q000628:therapy; D006095:Gram-Positive Cocci / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D009181:Mycoses / Q000175:diagnosis / Q000628:therapy; D009369:Neoplasms
chemical_list: D000165:Acridine Orange